• About
  • Subscribe
  • Advertise
  • Contact
Saturday, December 6, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

RANZCO won’t endorse new Cataract Clinical Care Standard

by rhiannon bowman
August 17, 2021
in Local, News
Reading Time: 4 mins read
A A
cataract surgery collaborative care

Approximately 83,000 cataract operations are performed in Australia's public system each year. Image: flywish/Shutterstock.com.

Share on FacebookShare on Twitter

The newly-launched national Cataract Clinical Care Standard has failed to win the full support of RANZCO, with the college citing two major issues with the finalised document.

In a memo to fellows and trainees, president Professor Nitin Verma said RANZCO won’t endorse the standard because it didn’t agree with the inclusion of 6/12 visual acuity as a measure for cataract, and the recommendation to offer all patients bilateral same day surgery.

The Australian Commission for Safety and Quality in Health Care (ACSQHC) has spent several years developing the inaugural Cataract Clinical Care Standard, which was released during a live webinar on Tuesday 17 August.

UPDATE: Since publication of this article, the ACSQHC issued its own response. 

Prof Nitin Verma.

RANZCO applauded the ACSQHC for taking the lead in developing the standard, which it described as “robust”, aside from the two matters it disagreed with.

“The broad range of stakeholder engagement has resulted in a comprehensive set of standards. RANZCO was represented by an ophthalmologist in the working group, and there were a number of ophthalmologists representing different parts of the sector,” Verma said.

However, based on the advice of its representative and after further extensive discussion and correspondence with ACSQHC, he said RANZCO decided not to endorse the standard.

“In particular, our concern regarding Snellen acuity as a prioritisation factor for cataract surgery does not align with any international standard,” Verma said.

“The survey of the [RANZCO] fellowship earlier this year showed that over 80% of the respondents advised that a correct acuity of 6/12 is not the most important determinant for surgical intervention for cataract patients, while 54% dismissed Snellen acuity as an appropriate measure to prioritise patients for surgery.”

Further, he said RANZCO “strongly disagreed” with the need to routinely discuss same or following day second-eye surgery.

Around 96% of respondents to the fellowship survey do not provide such a service.

“A similar percentile have views that same day sequential cataract surgery should not be offered as a routine alternative to surgery performed on separate days,” Verma said.

The college also shared with members it felt there is a “real risk” that some ophthalmologists will apply 6/12 visual acuity as a measure for cataract, and the recommendation to offer all patients bilateral same day surgery, in isolation and not consider all factors that go into making a decision about cataract surgery.

“We remain disappointed that the ACSQHC have not listened to the experts when making a final decision about the standards, as apart from these issues, they are very robust,” Verma said.

He said RANZCO supported its fellows being the best placed to make a recommendation to their patients about why and how cataract surgery should be performed.

“We strongly resist parts of the standards being used in isolation by hospitals or private health insurers to determine funding for cataract patients.”

More ‘appropriate and efficient’ treatment 

In a media release announcing the launch, the ACSQHC said it would help to define clear pathways of care so that decisions about cataract surgery were more consistent nationally and based on clinical need.

Conjoint Professor Anne Duggan, commission chief medical officer, said the new standard would ensure cataract treatment was appropriate and more efficient, with patients who are more likely to benefit from surgery being clearly identified.

“With increasing demand for cataract surgery due to improved surgical methods and an ageing population, it’s never been more important to ensure that we have the right care pathways,” she said.

“We need to ensure that cataract patients are prioritised for surgery or non-surgical alternatives based on both clinical need and individual circumstances. An additional benefit will be reduced public hospital waiting times.”

During the COVID pandemic, the necessary suspension of non-urgent elective surgery in some states and territories has delayed cataract surgeries, and led to growing waiting lists.

“While the standard was in development before the pandemic, COVID has increased the need for us to work together across the healthcare system to manage prioritisation for cataract surgery, with the common goal of improving the efficiency, effectiveness and equity of care,” Duggan said.

The new standard can be accessed online from Tuesday 17 August at safetyandquality.gov.au/cataract-ccs.

More reading

A black and white case? Snellen acuity and cataract surgery

Survey provides insight into Australian cataract surgery landscape

 

Tags: 6/12 visual acuityACSQHCAustralian Commission for Safety and Quality in Health CarecataractCataract Clinical Care StandardConjoint Professor Anne DugganendorseProfessor Nitin VermaRANZCOSnellen acuityvisual acuity

Related Posts

Macular disease consumes 12% of age pension payments, MDFA says. Images: dragonstock/stock.adobe.com & Robyn Mackenzie/Shutterstock.com.

Government flags major shift in PHI claiming for intravitreal injections

by Staff Writer
December 5, 2025

Eyecare practitioners are being advised to prepare for potential disruption to patient billing pathways, with the federal government considering changes...

The ASO believes expanding the medications optometrists can prescribe could put Australians at risk. Image: Johnstocker/stock.adobe.com.

‘We are not seeking to become doctors’ – OA responds to ASO concerns on prescribing

by Rob Mitchell
December 4, 2025

Optometry Australia (OA) says optometrists are “not seeking to become doctors” through proposed changes to rules governing the medicines they...

Associate Professor Raymond Wong (left) and Associate Professor Mohit Shivdasani have each received research funding. Image: Retina Australia

Pioneering sight-restoration projects secure Retina Australia funding

by Staff Writer
December 4, 2025

Retina Australia has announced the recipients of its 2026 research grants, funding two projects that aim to advance potential new...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited